grant

Quantitative Systems Pharmacology of Antibody Therapeutics across Diverse Biological Contexts

Organization UNIV OF NORTH CAROLINA CHAPEL HILLLocation CHAPEL HILL, UNITED STATESPosted 1 Feb 2024Deadline 31 Jan 2029
NIHUS FederalResearch GrantFY2025AddressAnimalsAntibodiesAntibody TherapyBindingBiologic ModelsBiologicalBiological ModelsBioluminescenceBiophysicsBody TissuesCell BodyCell CommunicationCell InteractionCell modelCell-to-Cell InteractionCellsCellular modelConstant RegionCoupledDataDevelopmentDimensionsDiseaseDisorderDrug KineticsDrugsEnergy TransferEnvironmentExhibitsIg Constant RegionImaging DeviceImaging InstrumentImaging ToolImaging technologyImmuneImmunesImmunoglobulin Constant RegionMathMathematicsMeasuresMediatingMedicationMethodsModel SystemModelingMolecular InteractionPK/PDPathologyPharmaceutical PreparationsPharmacokineticsPharmacologic ActionsPharmacologyPhysiologicPhysiologicalPhysiologyProcessResearchRoleSystemTherapeuticTherapeutic antibodiesTissuesTranslationsVariantVariationWorkantibody based therapiesantibody treatmentantibody-based therapeuticsantibody-based treatmentbiologicbiophysical foundationbiophysical principlesbiophysical sciencescell imagingcellular imagingdesigndesigningdevelopmentaldrug developmentdrug/agentimaging approachimaging based approachimmunological statusin vivoinsightmolecular imagingmolecule imagingneglectpatient populationpatient subclasspatient subclusterpatient subgroupspatient subpopulationspatient subsetspatient subtypespharmacokinetics and pharmacodynamicsrapid growthsocial rolespatial and temporalspatial temporalspatiotemporalsuccesstherapeutic agent developmenttherapeutic developmenttooltranslation
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

ABSTRACT
Antibody-based therapeutics have grown rapidly over the past two decades. However, many challenges limiting

the success of this drug class persist. First, the attrition rate remains high in antibody drug development. Second,

many antibody therapeutics exhibit only transient pharmacologic action. As a result, antibody therapeutics benefit…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Quantitative Systems Pharmacology of Antibody Therapeutics across Diverse Biological Contexts — UNIV OF NORTH CAROLINA C | Dev Procure